Biggest News Aggregation in the World
📰 Ryne Bio News

Ryne Bio News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Ryne Bio. Real-time updates on events, politics, business and more.

Kenai Therapeutics Announces 82 Million Series A Financing to Advance Next Generation Allogeneic Cell Therapies for Neurological Diseases

Kenai Therapeutics a biotechnology company leveraging induced pluripotent stem cell iPSC technology to discover and develop a platform of allogeneic neuron replacement cell therapies for neurological disorders today announced an 82 million Series A financing coled by Alaska Permanent Fund Corporation Cure Ventures and The Column Group with participation from Euclidean Capital and Saisei Ventures.
United States San Diego San Francisco Jeff Goater Jeff Jonas Tomoyuki Hasegawa

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science